DDC（薬物・機器コンビネーション）の世界市場レポート 2025年

DDC（薬物・機器コンビネーション）市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR11.9％で2,279億4,000万米ドルに成長します。予測期間の成長は、患者のエンパワーメントとエンゲージメント、ヘルスケアのデジタル化、世界市場の拡大、新規治療法の出現、価値ベースのヘルスケアに起因すると考えられます。予測期間の主な動向には、治療の進歩、複雑な疾患管理、患者中心のケア、技術革新、規制当局の支援などがあります。

DDC（薬物・機器コンビネーション）市場は、慢性疾患の有病率の増加により大幅な成長を遂げています。慢性疾患は、1年以上持続し、継続的な医療を必要とするもので、心臓病や糖尿病などの疾患が含まれます。治療薬と診断薬を含むDDC（薬物・機器コンビネーション）は、慢性疾患の患者を効果的に治療する上で極めて重要な役割を果たしています。世界保健機関（WHO）の報告書によると、糖尿病の世界罹患者数は2022年に4億2,000万人を突破し、2030年には5億7,800万人、2045年には7億人に増加すると予測されています。このような有病率の増加は、慢性疾患の管理におけるDDC（薬物・機器コンビネーション）の重要な役割を強調し、市場の成長を促進しています。

事故による死傷者の増加が、今後のDDC（薬物・機器コンビネーション）市場の成長を促進すると予想されます。事故とは、意図しない危害、損害、傷害、損失をもたらす予期せぬ出来事や予定外の出来事を指し、多くの場合、人為的ミス、過失、環境条件、機械的故障などの要因が絡み合って発生します。DDC（薬物・機器コンビネーション）は、的を絞った医療介入を提供し、患者の安全性を向上させることで、事故を管理・予防する上で不可欠です。例えば、2024年5月、カナダの政府機関であるカナダ運輸省は、2022年の自動車事故死者数が1,931人に達し、前年の合計1,821人から6.0％増加し、過去10年間で2番目に多い数字になったと報告しました。その結果、事故による死傷者数の増加が、DDC（薬物・機器コンビネーション）市場に拍車をかけています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のDDC（薬物・機器コンビネーション）PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のDDC（薬物・機器コンビネーション）市場：成長率分析
• 世界のDDC（薬物・機器コンビネーション）市場の実績：規模と成長, 2019-2024
• 世界のDDC（薬物・機器コンビネーション）市場の予測：規模と成長, 2024-2029, 2034F
• 世界のDDC（薬物・機器コンビネーション）総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のDDC（薬物・機器コンビネーション）市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自動注射器
• マイクロニードルパッチ
• デジタルピル
• スマート吸入器
• ドラッグデリバリーハイドロゲル
• 薬剤溶出レンズ
• その他の製品
• 世界のDDC（薬物・機器コンビネーション）市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 直接入札
• 小売販売
• その他の流通チャネル
• 世界のDDC（薬物・機器コンビネーション）市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 整形外科疾患
• 呼吸器疾患
• 糖尿病
• 腫瘍
• 心血管疾患
• その他の用途
• 世界のDDC（薬物・機器コンビネーション）市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• クリニック
• 病院
• 在宅ケア環境
• 外来診療センター
• その他のエンドユーザー
• 世界のDDC（薬物・機器コンビネーション）市場：自動注射器のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• プレフィルド自動注射器
• 再利用可能な自動注射器
• 世界のDDC（薬物・機器コンビネーション）市場：マイクロニードルパッチのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 溶解性マイクロニードルパッチ
• コーティングされたマイクロニードルパッチ
• 世界のDDC（薬物・機器コンビネーション）市場：デジタルピルのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 摂取可能なセンサー
• スマートカプセル
• 世界のDDC（薬物・機器コンビネーション）市場：スマート吸入器のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 定量噴霧式吸入器（MDI）
• ドライパウダー吸入器（DPI）
• 世界のDDC（薬物・機器コンビネーション）市場：ドラッグデリバリーハイドロゲルのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 注射用ハイドロゲル
• 局所用ハイドロゲル
• 世界のDDC（薬物・機器コンビネーション）市場：薬剤溶出レンズのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• コンタクトレンズ
• 眼内レンズ
• 世界のDDC（薬物・機器コンビネーション）市場：その他の製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経皮パッチ
• 埋め込み型ドラッグデリバリーシステム

第7章 地域別・国別分析

• 世界のDDC（薬物・機器コンビネーション）市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のDDC（薬物・機器コンビネーション）市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• DDC（薬物・機器コンビネーション）市場：競合情勢
• DDC（薬物・機器コンビネーション）市場：企業プロファイル
  • The 3M Company Overview, Products and Services, Strategy and Financial Analysis
  • Abbott India Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Biotronik SE & Co. KG Overview, Products and Services, Strategy and Financial Analysis
  • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Ypsomed Holding AG
• Micron Biomedical Inc.
• MetP Pharma AG
• Sonceboz SA
• Lepu Medical Technology（Beijing）Co. Ltd.
• Eitan Medical Ltd.
• Vaxess Technologies Inc.
• Subcuject Aps
• Allergan PLC
• Terumo Corporation
• Stryker Corporation
• Becton Dickinson and Company
• Zimmer Biomet Holdings Inc.
• MediPrint Ophthalmics
• Arrow International Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• DDC（薬物・機器コンビネーション）市場2029：新たな機会を提供する国
• DDC（薬物・機器コンビネーション）市場2029：新たな機会を提供するセグメント
• DDC（薬物・機器コンビネーション）市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Drug-device combinations refer to therapeutic and diagnostic products that combine a medical device with a drug, facilitating localized drug administration, precise drug targeting, and personalized therapy. These combinations create a unified entity, physically and chemically, packaged together in a single package. Drug-device combinations play a crucial role in clinical development, enabling the delivery of drugs to specific locations in the body.

The primary types of drug-device combination products include auto-injectors, microneedle patches, digital pills, smart inhalers, drug delivery hydrogels, drug-eluting lenses, and other products. These products find applications in various medical fields such as orthopedic diseases, respiratory diseases, diabetes, oncology, cardiovascular diseases, among others. The end users of drug-device combination products include clinics, hospitals, home care settings, ambulatory care centers, and others. These products are distributed through direct tenders, retail sales, and other distribution channels.

The drug-device combination market research report is one of a series of new reports from The Business Research Company that provides drug-device combination market statistics, including drug-device combination industry global market size, regional shares, competitors with an drug-device combination market share, detailed drug-device combination market segments, market trends and opportunities, and any further data you may need to thrive in the drug-device combination industry. This drug-device combination market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug device combination market size has grown rapidly in recent years. It will grow from $131.01 billion in 2024 to $145.29 billion in 2025 at a compound annual growth rate (CAGR) of 10.9%. The growth in the historic period can be attributed to increasing medical innovation, rise in chronic diseases, patient-centric approaches, advances in biologics, challenges of monotherapy, clinical needs.

The drug device combination market size is expected to see rapid growth in the next few years. It will grow to $227.94 billion in 2029 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to patient empowerment and engagement, healthcare digitalization, global market expansion, emergence of novel therapies, value-based healthcare. Major trends in the forecast period include therapeutic advancements, complex disease management, patient-centric care, technological innovations, and regulatory support.

The drug-device combination market is witnessing substantial growth driven by the increasing prevalence of chronic diseases. Chronic diseases, persisting for a year or longer and requiring ongoing medical care, include conditions like heart disease and diabetes. Drug-device combinations, encompassing therapeutic and diagnostic products, play a pivotal role in effectively treating individuals with chronic diseases. As per the World Health Organization's report, the global incidence of diabetes surpassed 420 million in 2022, with projections indicating a rise to 578 million by 2030 and 700 million by 2045. This escalating prevalence underscores the critical role of drug-device combinations in managing chronic diseases, thereby propelling the growth of the market.

An increase in casualties due to accidents is anticipated to drive the growth of the drug-device combination market in the future. Accidents refer to unexpected events or unplanned incidents that result in unintended harm, damage, injury, or loss, often arising from a mix of factors such as human error, negligence, environmental conditions, or mechanical failure. Drug-device combinations are essential in managing and preventing accidents by providing targeted medical interventions and improving patient safety. For example, in May 2024, Transport Canada, a government agency in Canada, reported that motor vehicle fatalities reached 1,931 in 2022, representing a 6.0% increase from the previous year's total of 1,821, and marking the second highest figure recorded in the past decade. Consequently, the rise in casualties resulting from accidents is fueling the drug-device combination market.

Major companies in the drug combination device market are developing innovative products like Trelegy Ellipta to maintain their market position. Trelegy Ellipta is an inhaler designed to deliver a specific dosage of medication directly to the lungs and is recognized as the first single-inhaler triple therapy. For example, in April 2022, GSK, a UK-based pharmaceutical and biotechnology company, introduced Trelegy Ellipta. This inhaler is a compact and portable device used to treat chronic obstructive pulmonary disease (COPD) and asthma. Ellipta inhalers can accommodate up to three different types of drugs in foil packaging for combination therapy. Trelegy Ellipta is a drug combination device that features three active ingredients: fluticasone furoate, umeclidinium, and vilanterol. It enhances patient management of respiratory conditions through its integrated delivery system.

Major companies in the drug-device combination market are introducing innovative products such as the G-Lasta Subcutaneous Injection 3.6 mg BodyPod to simplify the administration process. The G-Lasta Subcutaneous Injection 3.6 mg BodyPod is a drug-device combination that includes an automated injection device and G-Lasta (pegfilgrastim), a medication given to patients undergoing chemotherapy to reduce the occurrence of febrile neutropenia. For instance, in December 2022, Terumo Corporation, a Japan-based medical device company, collaborated with Kyowa Kirin, a Japan-based pharmaceutical company, to launch the G-Lasta Subcutaneous Injection 3.6 mg BodyPod. G-Lasta is utilized during chemotherapy to decrease the incidence of febrile neutropenia. The automated injection device is connected at the hospital on the day of chemotherapy and automatically administers the drug approximately 27 hours later. This feature eliminates the need for an extra outpatient visit, thereby easing the burden on patients.

In May 2023, Closed Loop Medicine Ltd, a UK-based TechBio company focused on developing combination prescription drug and software therapy products, formed a partnership with Pharmanovia. Through this collaboration, Closed Loop Medicine Ltd. aims to advance precision medicine strategies that utilize genetic and molecular profiling to determine the most effective drug combinations for individual patients. Pharmanovia is a pharmaceutical company based in the UK.

Major companies operating in the drug device combination market are The 3M Company, Abbott India Ltd., Biotronik SE & Co. KG, Boston Scientific Corporation, Medtronic PLC, Ypsomed Holding AG, Micron Biomedical Inc., MetP Pharma AG, Sonceboz SA, Lepu Medical Technology (Beijing) Co. Ltd., Eitan Medical Ltd., Vaxess Technologies Inc., Subcuject Aps, Allergan PLC, Terumo Corporation, Stryker Corporation, Becton Dickinson and Company, Zimmer Biomet Holdings Inc., MediPrint Ophthalmics, Arrow International Inc., Alcon Inc., W. L. Gore & Associates Inc., Cook Medical LLC, Pinnacle Biologics Inc.

North America was the largest region in the drug-device combination market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug device combination market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug device combination market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug-device combination market consists of sales of catheter and advanced wound care products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug Device Combination Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug device combination market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug device combination ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug device combination market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Auto-Injector; Microneedle Patch; Digital Pill; Smart Inhaler; Drug Delivery Hydrogels; Drug-Eluting Lens; Other Products
• 2) By Distribution Channel: Direct Tender; Retails Sales; Other Distribution Channels
• 3) By Application: Orthopedic Diseases; Respiratory Diseases; Diabetes; Oncology; Cardiovascular Diseases; Other Applications
• 4) By End User: Clinics; Hospitals; Home Care Settings; Ambulatory Care Centers; Other End Users
• Subsegments:
• 1) By Auto-Injector: Pre-Filled Auto-Injectors; Reusable Auto-Injectors
• 2) By Microneedle Patch: Dissolving Microneedle Patches; Coated Microneedle Patches
• 3) By Digital Pill: Ingestible Sensors; Smart Capsules
• 4) By Smart Inhaler: Metered-Dose Inhalers (MDIs); Dry Powder Inhalers (DPIs)
• 5) By Drug Delivery Hydrogels: Injectable Hydrogels; Topical Hydrogels
• 6) By Drug-Eluting Lens: Contact Lenses; Intraocular Lenses
• 7) By Other Products: Transdermal Patches; Implantable Drug Delivery Systems
• Companies Mentioned: The 3M Company; Abbott India Ltd.; Biotronik SE & Co. KG; Boston Scientific Corporation; Medtronic PLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug Device Combination Market Characteristics

3. Drug Device Combination Market Trends And Strategies

4. Drug Device Combination Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Drug Device Combination Growth Analysis And Strategic Analysis Framework

• 5.1. Global Drug Device Combination PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Drug Device Combination Market Growth Rate Analysis
• 5.4. Global Drug Device Combination Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Drug Device Combination Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Drug Device Combination Total Addressable Market (TAM)

6. Drug Device Combination Market Segmentation

• 6.1. Global Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Auto-Injector
• Microneedle Patch
• Digital Pill
• Smart Inhaler
• Drug Delivery Hydrogels
• Drug-Eluting Lens
• Other Products
• 6.2. Global Drug Device Combination Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct Tender
• Retails Sales
• Other Distribution Channels
• 6.3. Global Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Orthopedic Diseases
• Respiratory Diseases
• Diabetes
• Oncology
• Cardiovascular Diseases
• Other Applications
• 6.4. Global Drug Device Combination Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Clinics
• Hospitals
• Home Care Settings
• Ambulatory Care Centers
• Other End Users
• 6.5. Global Drug Device Combination Market, Sub-Segmentation Of Auto-Injector, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pre-Filled Auto-Injectors
• Reusable Auto-Injectors
• 6.6. Global Drug Device Combination Market, Sub-Segmentation Of Microneedle Patch, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dissolving Microneedle Patches
• Coated Microneedle Patches
• 6.7. Global Drug Device Combination Market, Sub-Segmentation Of Digital Pill, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ingestible Sensors
• Smart Capsules
• 6.8. Global Drug Device Combination Market, Sub-Segmentation Of Smart Inhaler, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metered-Dose Inhalers (MDIs)
• Dry Powder Inhalers (DPIs)
• 6.9. Global Drug Device Combination Market, Sub-Segmentation Of Drug Delivery Hydrogels, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Injectable Hydrogels
• Topical Hydrogels
• 6.10. Global Drug Device Combination Market, Sub-Segmentation Of Drug-Eluting Lens, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Contact Lenses
• Intraocular Lenses
• 6.11. Global Drug Device Combination Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transdermal Patches
• Implantable Drug Delivery Systems

7. Drug Device Combination Market Regional And Country Analysis

• 7.1. Global Drug Device Combination Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Drug Device Combination Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drug Device Combination Market

• 8.1. Asia-Pacific Drug Device Combination Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Drug Device Combination Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drug Device Combination Market

• 9.1. China Drug Device Combination Market Overview
• 9.2. China Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Drug Device Combination Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drug Device Combination Market

• 10.1. India Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Drug Device Combination Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drug Device Combination Market

• 11.1. Japan Drug Device Combination Market Overview
• 11.2. Japan Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Drug Device Combination Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drug Device Combination Market

• 12.1. Australia Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Drug Device Combination Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drug Device Combination Market

• 13.1. Indonesia Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Drug Device Combination Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drug Device Combination Market

• 14.1. South Korea Drug Device Combination Market Overview
• 14.2. South Korea Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Drug Device Combination Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drug Device Combination Market

• 15.1. Western Europe Drug Device Combination Market Overview
• 15.2. Western Europe Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Drug Device Combination Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drug Device Combination Market

• 16.1. UK Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Drug Device Combination Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drug Device Combination Market

• 17.1. Germany Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Drug Device Combination Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drug Device Combination Market

• 18.1. France Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Drug Device Combination Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drug Device Combination Market

• 19.1. Italy Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Drug Device Combination Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drug Device Combination Market

• 20.1. Spain Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Drug Device Combination Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drug Device Combination Market

• 21.1. Eastern Europe Drug Device Combination Market Overview
• 21.2. Eastern Europe Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Drug Device Combination Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drug Device Combination Market

• 22.1. Russia Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Drug Device Combination Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drug Device Combination Market

• 23.1. North America Drug Device Combination Market Overview
• 23.2. North America Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Drug Device Combination Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drug Device Combination Market

• 24.1. USA Drug Device Combination Market Overview
• 24.2. USA Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Drug Device Combination Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drug Device Combination Market

• 25.1. Canada Drug Device Combination Market Overview
• 25.2. Canada Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Drug Device Combination Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drug Device Combination Market

• 26.1. South America Drug Device Combination Market Overview
• 26.2. South America Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Drug Device Combination Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drug Device Combination Market

• 27.1. Brazil Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Drug Device Combination Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drug Device Combination Market

• 28.1. Middle East Drug Device Combination Market Overview
• 28.2. Middle East Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Drug Device Combination Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drug Device Combination Market

• 29.1. Africa Drug Device Combination Market Overview
• 29.2. Africa Drug Device Combination Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Drug Device Combination Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Drug Device Combination Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drug Device Combination Market Competitive Landscape And Company Profiles

• 30.1. Drug Device Combination Market Competitive Landscape
• 30.2. Drug Device Combination Market Company Profiles
  • 30.2.1. The 3M Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott India Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Biotronik SE & Co. KG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis

31. Drug Device Combination Market Other Major And Innovative Companies

• 31.1. Ypsomed Holding AG
• 31.2. Micron Biomedical Inc.
• 31.3. MetP Pharma AG
• 31.4. Sonceboz SA
• 31.5. Lepu Medical Technology (Beijing) Co. Ltd.
• 31.6. Eitan Medical Ltd.
• 31.7. Vaxess Technologies Inc.
• 31.8. Subcuject Aps
• 31.9. Allergan PLC
• 31.10. Terumo Corporation
• 31.11. Stryker Corporation
• 31.12. Becton Dickinson and Company
• 31.13. Zimmer Biomet Holdings Inc.
• 31.14. MediPrint Ophthalmics
• 31.15. Arrow International Inc.

32. Global Drug Device Combination Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drug Device Combination Market

34. Recent Developments In The Drug Device Combination Market

35. Drug Device Combination Market High Potential Countries, Segments and Strategies

• 35.1 Drug Device Combination Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Drug Device Combination Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Drug Device Combination Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer